Conversely, TRIM21/Ro52 enhances the proliferation and migration of cancer cells in glioma and thyroid cancer, while also contributing to increased drug resistance in colorectal and pancreatic cancers [23,24,25]. This evidence concerns the gene TRIM21 and thyroid gland carcinoma.